Recurrence and occurrence of kaposi's sarcoma in patients living with Human Immunodeficiency Virus (HIV) and on antiretroviral therapy, despite suppressed HIV viremia

Abstract

In 21 cutaneous and/or visceral Kaposi's sarcoma cases, occurring in patients living with human immunodeficiency virus (HIV) who were on antiretroviral therapy with suppressed HIV viremia and high CD4 T cell counts, the efficacy of conventional chemotherapies was limited due to cumulative toxicities, comedications, and a lack of immune improvement.